<DOC>
	<DOC>NCT01208779</DOC>
	<brief_summary>This observational study in estrogen receptor positive early breast cancer patients is aimed to evaluate the patients' compliance to aromatase inhibitor (AI) therapy and to collect country-specific data in estrogen receptor positive early breast cancer patients including data on demography, disease characteristics and disease management.</brief_summary>
	<brief_title>Epidemiology Study in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<criteria>Postmenopausal females with estrogen receptor positive breast cancer that are currently treated with aromatase inhibitor (AI) medication Provision of subject informed consent If participating in any clinical trial, the subject cannot take part in this study.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Compliance</keyword>
	<keyword>HR+ breast cancer</keyword>
	<keyword>epidemiology</keyword>
</DOC>